Individualized Low-Density Lipoprotein Cholesterol Reduction With Alirocumab Titration Strategy in Heterozygous Familial Hypercholesterolemia: Results From an Open-Label Extension of ODYSSEY LONG TERM
Journal of Clinical Lipidology - Netherlands
doi 10.1016/j.jacl.2018.11.007
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2019
Authors
Publisher
Elsevier BV